MOF as control arm for NSABP adjuvant chemotherapy trial.
Hellmann
K
K
Gilbert
J
J
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000188:drug therapy*; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D012673:Semustine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D012673:Semustine; D014750:Vincristine; D005472:Fluorouracil